Ute Simon

Ute Simon, Ph.D., joined Advanced Accelerator Applications (AAA), a Novartis company as Global Head of Medical Affairs in April 2020, following an ad interim appointment in January 2020.

Prior to this, Ute was Medical Director, Early Development & Scientific Relations, and Head Clinical Research for Novartis Pharma GmbH, Germany, since 2015. In this role, she supported the Pharma portfolio of Novartis by leading a team of 240 people across clinical development and medical affairs, with responsibility for all functional activities within clinical research, including investigator-initiated trials.

During her tenure with Novartis Pharma GmbH, Germany, Ute also served as the Ad Interim Chief Scientific Officer in 2019, with oversight for country Medical Affairs, field-based Medical Science, Medical Franchise, and Trial Regulatory teams, supporting over 100 studies per year for the German market.

From 2012 to 2015, Ute served as Cluster Head, Clinical Operations for Novartis Pharma GmbH, Germany, Austria and Switzerland. Prior to this, she was Group Head, Clinical Operations. Ute started her career as Lead Clinical Research Associate, Novartis Pharma GmbH, Germany, with a focus in Neuroscience and Immunology, from 2006 to 2009.

Since 2013, Ute has served as a Member of the Managing Board on several German academic and industry associations, such as the German Association of Research-Based Pharmaceutical Companies, the Paul Martini Foundation (promoting drug research and scientific exchange) the Bavaria California Technology Center and the Medical University of Brandenburg.

Ute earned her Ph.D., with honors, in Molecular Biology from Universität Halle an der Salle, Germany. She also studied biology and geography and holds a degree from Technische Universität Berlin.